About Montelukast Sodium Api Powder
| Grade Standard |
USP
|
| Grade |
Pharma Grade
|
| Packaging |
25Kg Bag
|
| CAS Number |
158966-92-8
|
| Purity |
>99%
|
| Usage/Application |
Pharmaceutical
|
| Molecular Weight |
586.2 g/mol
|
| Chemical Formula |
C35H36ClNO3S
|
| Minimum Order Quantity |
25 Kg
|
Product Specification
| Grade Standard |
IP |
| Grade |
Pharma Grade |
| Packaging |
25Kg Drum |
| Purity |
90%-95% |
| Usage/Application |
Pharmaceutical |
Product DescriptionGrade -ip/bp/uspi i i i
make-i morepen , medicarei
ready stocki
All documents will be providedi
High Purity and Stringent Quality ControlMontelukast Sodium API Powder offers unmatched quality, boasting 98.0% to 102.0% assay and a total impurity threshold of less than 1.0%. Manufactured with a strict focus on safety, it aligns with ICH guidelines for residual solvents, possesses extremely low heavy metal content (0.001%), and maintains compliance with rigorous microbial limits. Each batch is rigorously tested by IR and HPLC to ensure consistent identity and purity.
Secure Packaging and Stable StorageDelivered in double-layer LDPE bags housed within HDPE drums, Montelukast Sodium API Powder is protected from moisture and light. Best stored below 25C in tightly closed containers, it remains stable for up to two years. This robust packaging preserves the powder's pharmaceutical-grade integrity throughout shipping and storage, making it an ideal choice for global importers, exporters, manufacturers, and suppliers.
Pharmaceutical Versatility and UsageThe API's excellent physical and chemical characteristics-such as D90 < 20 microns particle size and pH 7.0-9.0 (1% solution)-facilitate its use across diverse anti-asthmatic and anti-allergic formulations. Its high solubility in ethanol and methanol ensures efficient formulation processes, while its certified purity supports reliable and effective therapeutics in the pharmaceutical market.
FAQ's of Montelukast Sodium Api Powder:
Q: How is Montelukast Sodium API Powder identified and tested for quality?
A: Montelukast Sodium API Powder is identified using Infrared Spectroscopy (IR) and High Performance Liquid Chromatography (HPLC). Each batch undergoes rigorous quality testing, including assay (98.0%-102.0%), impurity profiling, residual solvent analysis (as per ICH guidelines), and strict microbial limit testing to ensure its pharmaceutical-grade quality.
Q: What are the main benefits of using Montelukast Sodium API Powder?
A: Montelukast Sodium API Powder offers high purity (99%), stringent impurity control, stability, and compliance with international standards. Its excellent safety profile and pharmaceutical grade make it ideal for the manufacture of anti-asthmatic and anti-allergic medications that require reliable and consistent performance.
Q: When should Montelukast Sodium API Powder be used in the manufacturing process?
A: This API should be incorporated during the active ingredient phase of pharmaceutical formulation, where high purity and consistent physical properties are crucial. Formulators typically use it for oral dosage forms, taking advantage of its stability and solubility profile to ensure dosage accuracy and therapeutic effectiveness.
Q: Where is Montelukast Sodium API Powder produced and what packaging ensures its quality?
A: This product is manufactured in India and supplied globally. It is packaged securely in double-layer LDPE bags placed inside HDPE drums, protecting the powder from light and moisture, and maintaining its stability during transit and storage.
Q: What are the recommended storage conditions and shelf life for Montelukast Sodium API Powder?
A: It is advised to store the powder below 25C in a tightly closed container, protected from light and moisture. Under these recommended conditions, the shelf life of Montelukast Sodium API Powder is up to two years.
Q: How is the microbial safety of Montelukast Sodium API Powder maintained?
A: The powder adheres to strict microbial limits: total aerobic count less than 1000 cfu/g, yeast and molds below 100 cfu/g, and absence of harmful bacteria such as E. coli and Salmonella. These standards are regularly tested to ensure microbiological safety for pharmaceutical applications.